Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 62,073 shares at $7.00 ($435K) on 2025-11-03, disclosed to the SEC on 2025-11-04.
Open-market sale of $435k RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |
| RLAY | SELL | 2025-07-10 | $438K | — | Filing → |